A Phase 2 Study to Evaluate Efficacy, Safety, and Pharmacokinetics of GLWL-01 in the Treatment of Patients With Prader-Willi Syndrome
Phase of Trial: Phase II
Latest Information Update: 19 Jun 2019
Price : $35 *
At a glance
- Drugs GLWL 01 (Primary)
- Indications Prader-Willi syndrome
- Focus Therapeutic Use
- Sponsors GLWL Research
- 17 Jun 2019 Status changed from active, no longer recruiting to completed.
- 25 Feb 2019 Status changed from recruiting to active, no longer recruiting.
- 18 Jan 2019 Planned End Date changed from 1 Apr 2019 to 1 Jul 2019.